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Research Article
The CCR4–NOT complex maintains liver homeostasis
through mRNA deadenylation
Akinori Takahashi1,*, Toru Suzuki5,* , Shou Soeda1,* , Shohei Takaoka1 , Shungo Kobori2, Tomokazu Yamaguchi3 ,
Haytham Mohamed Aly Mohamed1 , Akiko Yanagiya1 , Takaya Abe4, Mayo Shigeta4, Yasuhide Furuta4, Keiji Kuba3 ,
Tadashi Yamamoto1,5
The biological significance of deadenylation in global gene ex-
pression is not fully understood. Here, we show that the CCR4–
NOT deadenylase complex maintains expression of mRNAs, such
as those encoding transcription factors, cell cycle regulators, DNA
damage response–related proteins, and metabolic enzymes, at
appropriate levels in the liver. Liver-specific disruption of Cnot1,
encoding a scaffold subunit of the CCR4–NOT complex, leads to
increased levels of mRNAs for transcription factors, cell cycle
regulators, and DNA damage response–related proteins because of
reduced deadenylation and stabilization of these mRNAs. CNOT1
suppression also results in an increase of immature, unspliced
mRNAs (pre-mRNAs) for apoptosis-related and inflammation-
related genes and promotes RNA polymerase II loading on their
promoter regions. In contrast, mRNAs encodingmetabolic enzymes
become less abundant, concomitant with decreased levels of these
pre-mRNAs. Lethal hepatitis develops concomitantly with abnor-
mal mRNA expression. Mechanistically, the CCR4–NOT complex
targets and destabilizesmRNAsmainly through its associationwith
Argonaute 2 (AGO2) and butyrate response factor 1 (BRF1) in the
liver. Therefore, the CCR4–NOT complex contributes to liver ho-
meostasis by modulating the liver transcriptome through mRNA
deadenylation.
DOI 10.26508/lsa.201900494 | Received 19 July 2019 | Revised 11 March
2020 | Accepted 14 March 2020 | Published online 1 April 2020
Introduction
In mammals, the liver is essential to control energy intake and
expenditure so as to maintain organismal energy homeostasis.
Disruption of liver function results in metabolic disorders and
diseases, including hepatitis, hepatic cirrhosis, liver cancer, mul-
tiple organ failure, and death (Malhi et al, 2010). Precise regulation
of gene expression is required for liver homeostasis. In the liver,
mRNAs encoding metabolic enzymes are regulated by transcription
factors (TFs) such as hepatocyte nuclear factors, peroxisome
proliferator–activated receptor α, and sterol regulatory element–
binding transcription factor 1 (Horton et al, 2002; Desvergne et al,
2006; Martinez-Jimenes et al, 2010). Although it is widely accepted
that transcription contributes to gene expression control, the
importance of posttranscriptional mechanisms, including mRNA
decay, for appropriate gene expression is increasingly appreciated
(Garneau et al, 2007; Schoenberg et al, 2012). For instance, DICER, an
enzyme for processing microRNAs, suppresses hepatocyte growth
and fetal stage–specific genes (Sekine et al, 2009).miR-122, the most
abundant microRNA in the liver, suppresses tumor-progressive
genes to prevent hepatocarcinogenesis (Hsu et al, 2012; Tsai et al,
2012). Thus, both transcriptional and posttranscriptional mecha-
nisms participate in liver homeostasis.
Shortening of polyadenosine (poly(A)) tails by deadenylation is
the initial step in the degradation of most mRNAs (Garneau et al,
2007; Schoenberg et al, 2012; Mugridge et al, 2018). Removal of the
poly(A) tail facilitates decapping of the 59 cap structure, leading to
59-39 exonuclease-mediated mRNA decay. After removal of the
poly(A) tail, mRNA degradation is also carried out from the 39-59 end
by the exosome complex, containing 39-59 exonucleases. The
CCR4–NOT (carbon catabolite repression 4–negative on TATA less)
complex, the major deadenylase in mammals, shortens mRNA
poly(A) tails (Temme et al, 2010; Nousch et al, 2013; Shirai et al, 2014).
This complex comprises at least eight subunits, CNOT1-3, either
CNOT6 or CNOT6L, either CNOT7 or CNOT8, and CNOT9-11 (Collart &
Timmers, 2004; Shirai et al, 2014). CNOT6/6L (CCR4a/b) and CNOT7/8
(CAF1a/b) catalytic subunits belong to the exonuclease–
endonuclease–phosphatase family and the DEDD (Asp-Glu-Asp-
Asp) family, respectively (Goldstrohm & Wickens, 2008). CNOT1
acts as a scaffold for the other subunits (Bai et al, 1999; Maillet et al,
2000; Collart & Timmers, 2004; Winkler & Whale, 2013). CNOT1 has
several domains, including a tristetraprolin (TTP)–binding domain,
the middle domain of eukaryotic initiation factor 4G (MIF4G)
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domain, which interacts with CNOT6/6L/7/8 enzymatic subunits, a
DUF3819 domain that interacts with CNOT9, and a NOT1 domain that
is required for interaction with CNOT2/3 ((Basquin et al., 2012; Petit
et al., 2012); (Bawankar et al., 2013); (Boland et al., 2013; Chen et al.,
2014; Fabian et al., 2013; Ukleja et al., 2016)). CNOT1 functions as the
scaffold for RNA-binding proteins that recruit the complex to the 39-
UTR of target mRNAs so as to degrade them. Those RNA-binding
proteins include the miRNA-induced silencing complex (miRISC),
which contains AGO family proteins and GW182 as core proteins, the
TTP family of AU-rich element (ARE)–binding proteins (TTP and
BRF1/2), ROQUIN, cytoplasmic polyadenylation element-binding
proteins, and NANOS (Fabian et al, 2011; Hosoda et al, 2011;
Adachi et al, 2014; Bhandari et al, 2014; Ogami et al, 2014; Sgromo et
al, 2017).
The CCR4–NOT complex participates in the regulation of cell
viability, energy metabolism, and tissue development via mRNA
degradation in a cell-type– and tissue-specific manner (Shirai et al,
2014). Suppression of the complex results in various forms of cell
death. Increased p53 or Caspase-4 leads to apoptosis in Cnot3-
depleted murine B-cells or Cnot2-depleted HeLa cells, respectively
(Ito et al, 2011a; Inoue et al, 2015). RIPK3-mediated necroptosis is
markedly induced in Cnot3-depleted MEFs (Suzuki et al, 2015),
whereas autophagy-independent ATG7/Trp53–mediated cell death
is observed in heart-specific, Cnot1/3-deficient mice (Yamaguchi et
al, 2018). In metabolic tissues, the CCR4–NOT complex deadenylates
mRNAs encodingmetabolic proteins such as PDK4 and UCP1 (Morita
et al, 2011; Takahashi et al, 2015). Excess nutrients affect CCR4–NOT
complex activity and expression of mRNAs that encode metabolic
proteins relevant to obesity (Morita et al, 2011; Takahashi et al, 2015).
The CCR4–NOT complex also regulates adipocyte function and liver
functional maturation (Li et al, 2017; Suzuki et al, 2019; Takahashi et
al, 2019). However, the mechanisms by which deadenylation reg-
ulates tissue-specific mRNA profiles and homeostasis have not
been fully addressed.
Our previous study showed that CCR4–NOT complex–mediated
decay of immature liver mRNAs is required for liver functional
maturation (Suzuki et al, 2019). In this study, we address the effects
of mRNA deadenylation on global gene expression and tissue
homeostasis in adult mature liver. We find that the CCR4–NOT
complex maintains the liver transcriptome via its deadenylase
activity. In mature liver, the CCR4–NOT complex binds to mRNAs
encoding TFs, cell cycle regulators, DNA damage response-related
proteins, and liver function–related proteins. Consequently, dis-
ruption of the CCR4–NOT function through CNOT1 depletion induces
aberrant gene expression that is associated with lethal hepatitis.
Therefore, the ability of the CCR4–NOT complex tomaintain the liver
transcriptome is crucial for liver homeostasis.
Results
Liver-specific disruption of Cnot1 causes lethal hepatitis
associated with elongated mRNA poly(A) tails
Suppression of CNOT1 largely abrogated deadenylase activity
(Temme et al, 2010; Ito et al, 2011; Nousch et al, 2013; Mostafa et al,
2020), suggesting that CNOT1 is an essential scaffold subunit in the
CCR4–NOT complex in vivo. We generated conditional KO mice for
Cnot1 (Cnot1fl/fl mice) by inserting loxP sequences into the Cnot1
gene locus so that exons 20 and 21 were deleted (Fig S1A and B).
Exons 20 and 21 encode amino acids 711-826 in CNOT1 protein and
are located N-terminal to the TTP-binding domain (Fig S1A and B).
Successful insertion of loxP sequences and generation of the KO
allele after Cre-mediated recombination were confirmed by PCR
analysis (Fig S1C and D). When we crossed heterozygous Cnot1-KO
(Cnot1+/−) males and females, wild-type and Cnot1+/− mice were
born at an ~1:1 ratio and grew normally to adulthood (Fig S1E).
Homozygous Cnot1-KO (Cnot1−/−) mice were not obtained after
embryonic day 8.5, indicating that Cnot1−/− mice die in embryo (Fig
S1E). Cnot1+/− mice were not born at Mendelian frequencies, sug-
gesting that Cnot1 haploinsufficiency partly affects mouse em-
bryonic development. The detailed reasons are to be addressed. To
understand the impact of CCR4–NOT complex–dependent dead-
enylation on gene expression and homeostasis in the liver, we
generated liver-specific Cnot1-KO mice (Cnot1-LKO mice). We ob-
tained Cnot1fl/fl;Alb-CreERT2 mice by crossing Cnot1fl/+;Alb-CreERT2
pairs. To induce deletion of the Cnot1 gene, Cnot1fl/fl;Alb-CreERT2
mice were fed with a tamoxifen-containing diet. Tamoxifen-fed
Cnot1fl/fl;Alb-CreERT2 mice were used as Cnot1-LKO mice (see de-
tails in the Materials and Methods section).
CNOT1 protein levels decreased in the livers of Cnot1-LKO mice
(Fig 1A). We first investigated whether Cnot1 suppression affects
liver function and causes physiological disorders. Cnot1-LKO mice
had pale-colored livers and swollen gallbladders (Fig 1B) and died
within 17 d after tamoxifen feeding (Fig 1C). 2 wk after tamoxifen
feeding, body weight and circulating blood glucose were signifi-
cantly lower in Cnot1-LKO mice than in control mice (Cnot1fl/fl or
Alb-CreERT2mice) (Fig 1D and E), although liver mass was similar (Fig
1F). Histological diagnosis using hematoxylin and eosin (H&E)–
stained liver sections revealed hepatocyte necrotic death and
infiltration of immune cells in livers of Cnot1-LKO, but not control
mice (Fig 1G and Table 1). Steatosis was hardly detected in livers of
Cnot1-LKO mice (Table 1). Consistent with this, levels of
inflammation-related and cell death–related mRNAs increased
significantly in the livers of Cnot1-LKO mice (Fig 1H). We also de-
tected an increase of phosphorylated-JNK, BAX, and Cleaved
Caspase-3 using immunoblot analysis (Fig 1A). The appearance of
Cleaved Caspase-3–positive cells in immunohistochemistry indi-
cated apoptotic death of hepatocytes in livers from Cnot1-LKOmice
(Fig 1I). Biochemical analysis of blood showed that alanine
transaminase (ALT), aspartate aminotransferase (AST), alkaline
phosphatase (ALP), and lactate dehydrogenase (LDH) levels were
strongly elevated in Cnot1-LKOmice (Table 2). These data suggested
that Cnot1-LKO mice died of severe hepatitis.
To examine the effects of CNOT1 suppression on the length of
RNA poly(A) tails, we compared poly(A) tail lengths of bulk RNAs in
the livers of control and Cnot1-LKO mice. In the livers of control
mice (Cnot1fl/fl or Alb-CreERT2), poly(A) tail lengths of ~60 nucleo-
tides (nt) were predominant (Fig 2A). In the livers from Cnot1-LKO
mice, the population of mRNAs with poly(A) tails longer than 70 nt
increased dramatically, whereas those with poly(A) tails of 30–70 nt
decreased (Fig 2A). To verify accumulation of long poly(A) mRNAs in
livers from Cnot1-LKO mice, we examined poly(A) tail lengths of
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Figure 1. Liver-specific disruption of Cnot1 causes lethal hepatitis.
(A) Immunoblottingof the indicatedmolecules in liver lysates fromAlb-CreERT2,Cnot1fl/fl, andCnot1-LKOmice. (B)Grossappearanceof livers fromAlb-CreERT2,Cnot1fl/fl, andCnot1-LKOmice.
(C) Survival curves of Alb-CreERT2 (n = 4), Cnot1fl/fl (n = 9), and Cnot1-LKO (n = 9)mice after a tamoxifen-containing diet. (D, E, F)Bodyweights (D), circulating blood glucose levels (E), and liver
weights (F) of Alb-CreERT2 (n = 4), Cnot1fl/fl (n = 7), and Cnot1-LKO (n = 9) mice. (G)H&E staining of livers from Alb-CreERT2, Cnot1fl/fl, and Cnot1-LKOmice. Scale bar, 100 μm. (H) Quantitative
real-time PCR (qRT-PCR) analysis of the indicated mRNAs in livers from Alb-CreERT2, Cnot1fl/fl, and Cnot1-LKO mice (n = 4). The Rplp0 mRNA level was used for
normalization. (I) Immunohistochemistry for Cleaved Caspase-3 in livers from Alb-CreERT2, Cnot1fl/fl, and Cnot1-LKO mice. Scale bar, 100 μm. Right graph shows
percentages of Cleaved Caspase-3–positive hepatocytes. Three different fields (total of ~500 cells) in each section were counted (Alb-CreERT2; n = 2, Cnot1fl/fl and
Cnot1-LKO mice; n = 3). Values in graphs represent means ± SEM. Unpaired t test, *P < 0.05, **P < 0.01, ***P < 0.001.
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individual mRNAs (Cox4i1, Gapdh, Pdk4, and TtrmRNAs). In the livers
from Cnot1-LKOmice, these mRNAs all had longer poly(A) tails than
those from control mice (Fig 2B). These data suggest that CCR4–NOT
complex–mediatedmRNA deadenylation is critical for liver function
and homeostasis.
Increased levels of TF-, cell cycle- and DNA damage-mRNAs and
decreased levels of liver function–related mRNAs in the livers of
Cnot1-LKO mice
We compared mRNA expression profiles in the livers of control
(Cnot1fl/fl) and Cnot1-LKOmice by performing total RNA sequencing
(RNA-seq). Using RNA-seq data, Fragments Per Kilobase of exons
per Million mapped sequence reads (FPKMs) of genes (Gene FPKMs,
where “Gene” designates any gene of interest) were calculated. The
results showed that 8,116 mRNAs increased and 703 decreased
more than twofold in the livers of Cnot1-LKO mice, compared with
those of controls (Fig 3A and Table S1). Gene ontology (GO) analysis
showed that GO terms “transcription,” “cell cycle,” and “cellular
response to DNA damage stimulus” were enriched among in-
creased mRNAs, whereas GO terms “oxidation–reduction process”
and “lipid metabolic process” were enriched among decreased
mRNAs (Fig 3B and Table S2). Consistent with hepatic cell death and
inflammation (Fig 1), “apoptosis” and “immune system process”
were also significantly enriched GO terms (Table S2). Furthermore,
FPKM distributions of mRNAs belonging to “transcription,” “cell
cycle,” or “cellular response to DNA damage stimulus”; TF-, cell
cycle-, or DNA damage-mRNAs were significantly higher in the livers
from Cnot1-LKOmice, compared with those of controls (Cnot1fl/fl or
Alb-CreERT2) (Fig S2A). In contrast, there was no significant differ-
ence in FPKM distribution of mRNAs belonging to GO terms
“oxidation–reduction process” and “lipid metabolic process” in the
livers from control and Cnot1-LKOmice, indicating that only some of
themRNAs that encodemolecules involved in “oxidation–reduction
process” and “lipid metabolic process” decreased in Cnot1-LKO
mice (Fig S2A). We verified these expression differences using
quantitative real-time PCR (qRT-PCR) analysis and showed that TF-,
cell cycle-, and DNA damage-mRNAs increased in the livers from
Cnot1-LKOmice (Fig 3C). In contrast, mRNAs encoding molecules for
oxidation–reduction process, lipid metabolic process, and other
liver-related functions decreased in the livers from Cnot1-KO livers
(Fig 3C). We performed poly(A) tail analyses on several TF-, DNA
damage-, and cell cycle-mRNAs. The results showed that mRNAs
encoding TFs (Trp53 and Jun), DNA damage response–related
molecules (Bbc3 and Brca1), and cell cycle regulators (Cdt1 and
Cdc25a) had longer poly(A) tails in livers of Cnot1-LKOmice (Fig 3D).
Poly(A) tail lengths of Cxcl10 mRNA in the livers of Cnot1-LKO mice
were similar to those in controls, although the band intensity in-
creased, suggesting that some mRNAs responsible for “immune
system process” increase, regardless of poly(A) elongation (Fig S2B).
mRNAs preferentially bound by the CCR4–NOT complex are
maintained at low levels, at least in part, because of mRNA decay
in liver
Total RNA for RNA-seq was prepared from livers of Cnot1-LKO mice
14 d after tamoxifen administration, when they were about to die
(Fig 1C). Although GO analysis clearly explained the severely
damaged livers in Cnot1-LKO mice, the data do not necessarily
imply a direct CNOT1 effect in liver. To examine whether TF-, cell
cycle-, and DNA damage-mRNAs, which increased in livers from
Cnot1-LKO mice, are controlled by the CCR4–NOT complex in the
liver, we conducted RNA immunoprecipitation (RIP) followed by
RNA-seq (RIP-seq). When we performed immunoprecipitation using
anti-CNOT3 antibody, other subunits of the CCR4–NOT complex
were efficiently co-purified (Fig S3A). Gel filtration chromatography
showed that CNOT3, as well as the other complex subunits, were
present in the same molecular weight fractions, suggesting that
almost all CNOT3 existed as a component of CCR4–NOT complex in
the liver (Fig S3B). We, thus, reasoned that RIP using anti-CNOT3
antibody (CNOT3-IP) represented levels of CCR4–NOT–RIP. To ex-
amine the relationship between the expression level and binding of
the CCR4–NOT complex to each mRNA, we normalized gene FPKMs
Table 1. Histopathological analysis of livers.
Sample name Inflammationa Steatosisb Hepatocellular necrosisc Histological score (0–9)
Cnot1-LKO 1 3 0 3 6
Cnot1-LKO 2 3 0 3 6
Cnot1 (fl/fl) 1 0 0 0 0
Cnot1 (fl/fl) 2 0 0 0 0
Alb-CreERT2 1 0 1 0 1
Alb-CreERT2 2 0 0 0 0
a0, no inflammation; 1, mild lymphocytic infiltration in the portal triad; 2, severe lymphocytic infiltration in portal triad; 3, extended infiltration of lymphocytes
throughout the liver.
b0, no steatosis; 1, microsteatosis; 2, microsteatosis and mild macrosteatosis; 3, severe macrosteatosis.
c0, no necrosis; 1, mild necrosis; 2, moderate necrosis; 3, severe necrosis.
Table 2. Serum profiles of control and Cnot1-LKO mice.
Cnot1 (fl/fl) (n = 3) Cnot1-LKO (n = 3) P-value
AST (IU/L) 3.17E+02 ± 44.6 5.26E+03 ± 1.5E+03 9.36E−03
ALT (IU/L) 3.60E+01 ± 1.15 9.48E+03 ± 2.64E+03 2.33E−02
ALP (IU/L) 1.16E+03 ± 88.8 1.06E+04 ± 1.04E+03 8.16E−04
LDH (IU/L) 1.01E+03 ± 73.6 6.94E+03 ± 8.32E+02 2.08E−03
Values represent means ± SEM.
Statistical significance was determined by t test.
The CCR4–NOT complex maintains liver homeostasis Takahashi et al. https://doi.org/10.26508/lsa.201900494 vol 3 | no 5 | e201900494 4 of 19
Figure 2. Elongated poly(A) tails of RNAs in livers from Cnot1-LKO mice.
(A) Poly(A) tail lengths of bulk RNA in livers from Alb-CreERT2, Cnot1fl/fl, and Cnot1-LKO mice. The lower graph shows a densitogram of poly(A) tail lengths in each
genotype. Signal intensity was normalized to total intensity (%). Values represent the mean of independent experiments (Alb-CreERT2; n = 2, Cnot1fl/fl and Cnot1-LKOmice;
n = 3). (B) Poly(A) tail lengths of the indicatedmRNAs in livers from Alb-CreERT2, Cnot1fl/fl, and Cnot1-LKOmice. PCR products of RNAs treated with RNase H in the presence of
oligo (dT) primer, which indicates that fragments without poly(A) tails were also loaded.
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Figure 3. Increase of TF-, cell cycle-, and DNA damage-mRNAs and decrease in liver function–related mRNAs in livers from Cnot1-LKO mice.
(A) Scatterplot ofmRNA FPKMs in livers from Cnot1fl/fl and Cnot1-LKOmice. Each dot represents themeanof four independent samples.mRNAs that increased or decreased >2-fold in
livers from Cnot1-LKOmice comparedwith those from Cnot1fl/flmice are shown in red or blue, respectively (Mann–WhitneyU-test, false discovery rate < 0.05). (B) EnrichedGO categories
in whichmRNAs increased or decreased >2-fold in livers from Cnot1-LKOmice compared with those from Cnot1fl/flmice. (C) qRT-PCR analysis of the indicatedmRNAs in livers from Alb-
CreERT2, Cnot1fl/fl, and Cnot1-LKOmice (n = 4). The Rplp0mRNA level was used for normalization. Values in graphs represent means ± SEM. Unpaired t test, *P < 0.05, **P < 0.01, ***P <
0.001. (D) Poly(A) tail lengths of the indicated mRNAs in livers from Alb-CreERT2, Cnot1fl/fl, and Cnot1-LKOmice. PCR products of RNAs treated with RNase H in the presence of oligo (dT)
primer, which indicates that fragments without poly(A) tails were also loaded.
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in RIP using gene FPKMs in input total RNA (defined as the
CCR4–NOT–RIP enrichment value). TF-, cell cycle-, and DNA damage-
mRNAs showed higher CCR4–NOT–RIP enrichment values than liver
function–related mRNAs (Fig 4A and B and Table S3). Binding of the
CCR4–NOT complex to those mRNA species was confirmed with qRT-
PCR of CCR4–NOT–RIP samples from the whole liver (Fig S3C). We
obtained similar qRT-PCR results with TF-, cell cycle-, and DNA
damage-mRNAs after CCR4–NOT–RIP using isolated hepatocytes (Fig
S3D), indicating that the CCR4–NOT complex controls the levels of
these mRNAs in hepatocytes. On the other hand, binding of the
CCR4–NOT complex to Cxcl10 and Tlr3 mRNAs was not significant in
isolated hepatocytes (Fig S3D). Therefore, it is possible that some
mRNAs detected in CCR4–NOT–RIP using whole liver lysates, in par-
ticular “immune system process”–related mRNAs, are from cells other
than hepatocytes. When we ranked mRNA species according to their
FPKMs in liver, TF-, cell cycle-, and DNA damage-mRNAs generally
belonged to the lower expression group compared with liver
function–related mRNAs (Fig 4C and D and Table S4). Furthermore,
mRNAs expressed at lower levels in the liver had higher CCR4–NOT–RIP
enrichment values (Fig 4E). These findings suggest that the CCR4–NOT
complex binds to more mRNA species that are expressed at low levels
in the liver, such as TF-, cell cycle-, and DNA damage-mRNAs, than to
mRNA species that are expressed at high levels in the same tissue,
such as liver function–related mRNAs. Similar results were obtained
when we used the medians of both RIP enrichment values and FPKMs,
instead of the means (Fig S4).
We next examined whether binding of the CCR4–NOT complex to
mRNAs influences their decay rates in the liver. We performed chase
experiments by injecting the transcription inhibitor, actinomycin D
(Act. D), into mice. Total RNAs were prepared from Act. D–injected
mouse livers and were subjected to RNA-seq. We calculated mRNA
half-lives using the RNA-seq results (see the Materials and Methods
section). Because levels of many mRNA species decrease as a result
of mRNA decay in Act. D–treated samples, normalization with a level
of stable mRNA will be more effective for calculation of mRNA half-
lives than genome-wide normalization methods. We normalized
gene FPKMs with the FPKM of 60S acidic ribosomal protein P0 (Rplp0)
mRNA, which was stable during 8 h Act. D treatment (Fig S5). We
compared the calculated mRNA half-lives in this study with previ-
ously reported data from chase experiments (Friedel et al, 2009;
Sharova et al, 2009; Schwanhausser et al, 2011). Although the data
were from NIH3T3 and mouse embryonic stem cells, there was weak,
but significant correlation between our data and the others, sug-
gesting that Act. D chase experiments using mice worked properly
(Fig S6A). We found that TF-, cell cycle-, and DNA damage-mRNAs
have relatively shorter mRNA half-lives than liver function–related
mRNAs (Fig 4F and G and Table S5). Overall, mRNAs that have shorter
half-lives showed higher CCR4–NOT–RIP enrichment values and
lower expression (Fig 4H and I). These data suggest that TF-, cell
cycle-, andDNAdamage-mRNAs are targeted for degradation and are
restricted to relatively low expression levels in the liver in a CCR4–
NOT complex–dependentmanner. In contrast, mRNA species that are
expressed at high levels in the liver seem to escape binding of the
CCR4–NOT complex and subsequent decay.
Elongation of mRNA half-lives in livers from Cnot1-LKO mice
By comparingmRNA half-lives in the livers of control and Cnot1-LKO
mice, we found that 6,718 mRNAs, had longer half-lives (Cnot1-LKO/
control >2.0) and 187 mRNAs had shorter half-lives (Cnot1-LKO/
control <0.5) in the livers from Cnot1-LKOmice (Fig 5A and Table S6).
mRNAs in the GO categories “transcription,” “cell cycle,” and
“cellular response to DNA damage stimulus” had significantly
longer half-lives in the livers of Cnot1-LKO mice than in those of
control mice (Figs 5B and S6B). We found that stabilized mRNAs had
higher CCR4–NOT–RIP enrichment values than mRNAs that were
destabilized or unchanged (half-lives, 0.5< Cnot1-LKO/control <2.0)
in the livers from Cnot1-LKO mice compared with control mice (Fig
5C). Furthermore, CCR4–NOT–RIP enrichment values correlated
significantly with the increase in gene FPKMs andmRNA half-lives in
livers (Cnot1-LKO/control) (Fig 5D and E). Therefore, CCR4–NOT–RIP
enrichment values basically represent the dependency of mRNAs
on CCR4–NOT complex–mediated decay. It should be noted that
mRNAs involved in “oxidation–reduction process” and “lipid met-
abolic process” had longer half-lives in the livers from Cnot1-LKO
mice (Fig 5B). These data suggest that mRNAs displaying low
CCR4–NOT–RIP enrichment values in the liver are also controlled by
the CCR4–NOT complex, although loss of control did not necessarily
lead to an increase in their expression levels.
The CCR4–NOT complex destabilizes mRNAs mainly through BRF1
and AGO2 in the liver
We next sought to determine how those mRNAs are targeted by the
CCR4–NOT complex. As BRF1 or AGO2 interacts with the CCR4–NOT
complex (Fabian et al, 2011; Adachi et al, 2014), we conducted RIP-
seq using antibodies against BRF1 and AGO2 (Tables S7 and S8).
Immunoprecipitated BRF1 and AGO2 were verified by immunoblot
analysis (Fig 6A). We analyzed RNA-seq data of BRF1–RIP and found
that 25 of the top 30 enriched mRNAs in BRF1–RIP had consensus
AU-rich motifs. Those are not enriched in the control IgG-IP (Table
S7). Furthermore, in BRF1–RIP, only 33 mRNAs were included among
the top 1,500 enriched mRNAs in control IgG-IP. miR-122 is an
abundant liver miRNA that accounts for 70% of liver total miRNAs.
We found that manymiR-122 targets, such as Aldoa, Map3k1, Ndrg3,
and Bcl9mRNAs, were enriched in AGO2–RIP (Tsai et al, 2012; Luna et
al, 2017 and Table S8). Again, they were not enriched in control IgG-
IP. These data suggest that both BRF1–RIP and AGO2–RIP worked
properly. Scatterplots showed that CCR4–NOT–RIP enrichment
values were significantly correlated with BRF1–RIP or AGO2–RIP
enrichment values (Fig 6B and C). Consistent with this, mRNAs that
showed high BRF1–RIP or AGO2–RIP enrichment values (>1.5) were
included in mRNA groups showing relatively high CCR4–NOT–RIP
enrichment values (Fig 6D). Furthermore, many mRNAs that were
stabilized (half-lives, Cnot1-LKO/control >2.0) in the livers from
Cnot1-LKO mice were included in mRNA groups showing high
BRF1–RIP or AGO2–RIP enrichment values (Fig 6E and F). In total,
3,589 species of mRNA were stabilized in the livers from Cnot1-LKO
mice (half-lives, Cnot1-LKO/control >2.0) and largely enriched in
CCR4–NOT–RIP (enrichment >1.5). Around half of 3,589 mRNAs were
common in those enriched in both BRF1–RIP and AGO2–RIP (Fig 6G).
These results suggest that the CCR4–NOT complex promotes
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Figure 4. The CCR4–NOT complex preferentially binds to TF-, cell cycle-, and DNA damage-mRNAs and maintains their expression at low levels.
(A)mRNAs were ordered according to their CCR4–NOT–RIP enrichment values. The x-axis represents ranking in ascending order. The CCR4–NOT–RIP enrichment value
represents gene FPKMs in RNA included in the anti-CNOT3 immunoprecipitates normalized against gene FPKMs in the liver total RNA (Input). Means of the values in three
independent experiments were used. Representative mRNAs possessing specific functions are shown in red (cell cycle), black (transcription), green (DNA damage
response), and blue (metabolism). (A, B) Violin plot of CCR4–NOT–RIP enrichment values calculated in (A) for all mRNAs, and those categorized in the indicated GO
terms. (C) mRNAs were ordered according to their FPKMs in livers from control mice (means of the values in four mice). (A) The x-axis represents ranking in ascending
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degradation of a variety of mRNAs, mainly through BRF1- or AGO2-
mediated target recognition in the liver. Finally, we found that
sequences enriched with U or A; “TTTTGT T/G T” and “TTTTTAAA”
were frequently observed in the 39-UTRs of stabilized, but not
destabilized mRNAs in the livers from Cnot1-LKO mice (Fig S7).
Differential expression of pre-mRNAs in the livers between
control and Cnot1-LKO mice
In the livers from Cnot1-LKOmice, more than 80% of themRNAs that
we analyzed showed both elongated half-lives and increased ex-
pression compared with control livers (Fig 7A). On the other hand,
around 10% of the mRNAs expressed at lower levels in the livers
from Cnot1-LKO mice than in controls had elongated half-lives
unexpectedly (Fig 7A). As steady-state mRNA levels are determined
by both mRNA synthesis and degradation, we examined whether
the transcription state was altered in the livers from Cnot1-LKO
mice. Previous reports showed that changes in pre-mRNA levels are
significantly correlated with transcription rates (Gaidatzis et al,
2015; Wang et al, 2018). We performed comprehensive profiling of
pre-mRNAs by counting the number of intron sequence reads
(intron reads) using RNA-seq data in the livers from control and
Cnot1-LKO mice (Table S9). The mRNA synthesis rate divided by the
mRNA decay rate is defined as the steady-state level of mRNA
(Palumbo et al, 2015), and the mRNA decay rate is related to the
reciprocal of the half-life (Chen et al, 2008). By considering pre-
mRNA levels as the mRNA synthesis rate, mRNA expression level
could be estimated by multiplying mRNA half-lives and pre-mRNA
levels. Calculated values corresponded well to mRNA expression
values obtained from RNA-seq, further suggesting that pre-mRNA
levels are good proxies for transcription rates (Fig S8A).
The landscape of intron reads was similar to that of exon counts
(compare Fig S8B and C with Figs 3A and S2A), although there was no
statistical significance in differences of pre-mRNA expression levels
between control and Cnot1-LKO mice. To determine whether specific
pre-mRNAs were differentially expressed in the livers of control and
order. Representative mRNAs are shown as in (A). (B, D) Violin plot of FPKMs for all mRNAs and grouped mRNAs as in (B). (E) Scatterplot of CCR4–NOT–RIP enrichment
values and mRNA FPKMs in livers from control mice. (F) Calculation of mRNA half-lives using RNA-seq results of liver total RNAs, which were prepared from Act. D–injected
control (Cnot1fl/fl) mice, are described in the Materials and Methods section. mRNAs were ordered according to lengths of their half-lives. The x-axis represents ranking in
ascending order. (A) Representative mRNAs are shown as in (A). (B, F, G) Violin plot of mRNA half-lives calculated in (F) for all mRNAs and grouped mRNAs as in (B). (H)
Scatterplot of CCR4–NOT–RIP enrichment values and mRNA half-lives in livers from control mice. (I) Scatterplot of mRNA half-lives and FPKMs in livers from control mice.
(E, H, I) Spearman’s rank correlation coefficients (rho) and P-values were calculated (E, H, I). (A, F) Note that representative mRNAs missing in (A) and (F) did not satisfy
criteria for the analyses (see the Materials and Methods section).
Figure 5. Elongated half-lives of mRNAs in livers from
Cnot1-LKO mice, and correlation between mRNA
stabilization and RIP enrichment.
(A) Scatterplot of mRNA half-lives in livers from control
(Cnot1fl/fl) and Cnot1-LKO mice. Calculation of mRNA
half-lives in livers from Cnot1-LKOmice was performed
as in Fig 4F (see the Materials and Methods section).
mRNAs with half-lives elongated or shortened in
livers from Cnot1-LKO mice by more than twofold
compared with those from Cnot1fl/fl mice, are shown in
red or blue, respectively. (B) Violin plot of half-lives
for all mRNAs and those categorized in the indicated
GO terms in the livers from control (Cnot1fl/fl) and Cnot1-
LKO mice. (C) Violin plot of CCR4–NOT–RIP
enrichment values in livers from control (Cnot1fl/fl)
mice (means of three independent experiments) for all
mRNAs, stabilized, destabilized, and unchanged
mRNAs (changes in half-lives: Cnot1-LKO/control >2.0,
<0.5, and the others, respectively). (D) Scatterplot of
CCR4–NOT–RIP enrichment values and changes in
FPKMs in livers (Cnot1-LKO/control). (E) Scatterplot of
CCR4–NOT–RIP enrichment values and changes of
mRNA half-lives in livers (Cnot1-LKO/control). (D, E)
Spearman’s rank correlation coefficient (rho) and
P-value were calculated (D, E). (B, C) Wilcoxon
signed-rank test (B) and Wilcoxon rank sum test
(C) were used. *P < 0.05, **P < 0.01, ***P < 0.001.
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Cnot1-LKO mice, we performed qRT-PCR analysis using intron region–
specific primers. The results showed that pre-mRNA levels of “immune
systemprocess”–related genes (Mx1andCxcl10) and “apoptosis”-related
genes (Ripk3, Pmaip1, and Bax) increased in the livers of Cnot1-LKOmice
(Fig 7B). Pre-mRNA levels of genes encoding TFs (Trp53, Sp3, Tbp, and Irf9)
and cell cycle-related genes (Cdt1 and Cdc25a) were comparable in the
liversof control andCnot1-LKOmice (Fig 7C).We found thatbindingmotifs
for interferon regulatory factor (IRF) proteins or Trp53 were enriched in
the promoter regions of “immune system process”–related genes or
“apoptosis”-related genes, which increased in the livers from Cnot1-LKO
mice at pre-mRNA levels, respectively (Fig S9). To examine whether the
increase in pre-mRNA levels was relevant to transcriptional activation,
we conducted chromatin immunoprecipitation assay (ChIP) using an
antibody against RNA polymerase II. The results showed that RNA
polymerase II occupancy on genomic regions of “immune system
process”–related genes (Ccl2 and Cxcl10) and “apoptosis”-related genes
(Ripk3, Pmaip1, and Bax) increased in the livers from Cnot1-LKOmice (Fig
7D). Therefore, it is possible that Trp53 and IRF9 proteins increased
Figure 6. The CCR4–NOT complex destabilizes mRNAs mainly through BRF1 and AGO2 in liver.
(A) Immunoblot analysis of anti-BRF1 (upper) or anti-AGO2 (lower) immunoprecipitates that were used for RIP-seq. (B, C) Scatterplots of CCR4–NOT–RIP enrichment
values versus BRF1–RIP enrichment values (BRF1–RIP FPKM/Input FPKM) (B), or versus AGO2–RIP enrichment values (AGO2–RIP FPKM/Input FPKM) (C) in livers from control
mice. (D) Violin plot of CCR4–NOT–RIP enrichment values in all mRNAs, BRF1-bound mRNAs (BRF1–RIP enrichment values > 1.5), and AGO2-bound mRNAs (AGO2–RIP
enrichment values > 1.5) in livers from control mice. (E, F) Violin plots of BRF1–RIP (E) or AGO2–RIP (F) enrichment values for all mRNAs and grouped mRNAs, as in Fig 5C.
(G) Venn diagram ofmRNAs showing elongated half-lives in livers from Cnot1-LKOmice (changes in half-lives: Cnot1-LKO/control >2.0). mRNAs with RIP enrichment values
more than 1.5 in CCR4–NOT–RIP (green), BRF1–RIP (red), and AGO2–RIP (blue) were compared. (B, C, D, E, F)Means of values in three independent experiments were used (B,
C, D, E, F). (B, C) Spearman’s rank correlation coefficient (rho) and the P-value were calculated (B, C). (D, E, F)Wilcoxon rank sum test (D, E, F), *P < 0.05, **P < 0.01, ***P <
0.001.
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because of mRNA stabilization and subsequently induced the tran-
scription of “immune system process”–related and “apoptosis”-related
genes in the livers from Cnot1-LKO mice. This could partly explain why
Cxcl10mRNA increasedwithout poly(A) elongation in Cnot1-LKOmice (Fig
S2B). It is also possible that infiltration of immune cells into the livers of
Cnot1-LKO mice contributes to the increase (Fig 1). On the other hand,
pre-mRNA levels of liver function–related genes (Aldh2, Cps1, and Gck)
significantly decreased in the livers from Cnot1-LKO mice (Fig 7B).
Therefore, expression of some genes involved in “oxidation–reduction
process” and “lipid metabolic process” decreased at pre-mRNA levels in
the livers from Cnot1-LKO mice. RNA polymerase II occupancy on the
genomic region of the Gck gene decreased significantly in the livers from
Cnot1-LKO mice compared with control mice (Fig 7D). These results
suggest that decreased transcription of some liver function–related
genes overwhelmed mRNA stabilization, resulting in decreases of their
mRNA levels.
Indirect effects of Cnot1 deficiency on the liver transcriptional
program
Previous studies have shown that the CCR4–NOT complex exists
in the nucleus and directly facilitates transcription in yeast and
certain types of mammalian cells (Collart & Struhl, 1994;
Badarinarayana et al, 2000; Hu et al, 2009; Kruk et al, 2011; Miller &
Reese, 2012; Cejas et al, 2017). We examined subcellular localization
of subunits of the CCR4–NOT complex as well as relevant tran-
scription regulators in the mouse liver. CNOT1 and CNOT2 were
localized in the cytoplasm but were barely detectable in the nu-
cleus (Fig 8A and B). Although Trp53 and TBP were expressed at very
low levels in livers from control mice, they were significantly el-
evated in both the nuclei and cytoplasm in the livers from Cnot1-
LKOmice (Fig 8A and B). RPB1, a component of RNA polymerase II,
and IRF9 increased significantly in the livers from Cnot1-LKO
Figure 7. Increase in immune system process- and apoptosis-genes and decrease in liver-related genes at pre-RNA levels in livers from Cnot1-LKOmice partly reflect
changes in transcription.
(A) Scatterplot of changes in mRNA half-lives and FPKMs (Cnot1-LKO/control). (B, C) qRT-PCR analysis of the indicated pre-mRNAs in livers from control (Alb-CreERT2 and
Cnot1fl/fl) and Cnot1-LKOmice (n = 4). Pre-mRNA levels were normalized with the Rplp0 pre-mRNA level. (D) ChIP-assay using the antibody against RNA polymerase II (Pol II)
or control IgG. qRT-PCR analysis of co-immunoprecipitated genome DNA fragments in livers from control (Cnot1fl/fl) and Cnot1-LKOmice was performed using primers in
genomic regions of the indicated genes. Percentages against input genome DNA were calculated (n = 3). Values in graphs represent means ± SEM. Unpaired t test, *P < 0.05,
**P < 0.01, ***P < 0.001.
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mice, in the nuclear or cytoplasmic fraction, respectively (Fig 8A
and B). Consistent with the cytoplasmic localization of CNOT1 and
CNOT2, we did not detect interaction of the CCR4–NOT complex
with RPB1 and TBP (Fig S3A). Taken together, these data suggest
that the CCR4–NOT complex does not directly influence transcrip-
tion in the liver and that impaired mRNA degradation in the absence
of CNOT1 secondarily influences transcription or other mRNA reg-
ulatory processes.
Discussion
In this study, we provide evidence that the CCR4–NOT deadenylase
complex plays critical roles in liver homeostasis. Liver-specific
disruption of Cnot1, which encodes a scaffold subunit of the
complex, resulted in substantial elongation of bulk RNA poly(A)
tails, as in the case of Drosophila S2 cells, Caenorhabditis elegans,
and MEFs (Temme et al, 2010; Nousch et al, 2013; Mostafa et al, 2020),
further indicating an essential role of CNOT1 in CCR4–NOT
complex–mediated mRNA deadenylation in vivo. Consistent with
previous reports that poly(A) tails stabilize mRNAs in eukaryotes
(Dreyfus & Regnier, 2002; Weill et al, 2012), more than 80% of the
mRNAs that we analyzed showed elongated half-lives in livers from
Cnot1-LKO mice (Fig 7A). Therefore, the CCR4–NOT complex is the
major mRNA decay mechanism promoting mRNA turnover in the
liver.
Short mRNA half-lives correlated with reduced mRNA levels in
HeLa cells and mouse liver (Maekawa et al, 2015, and this study).
This suggests that mRNA decay mechanisms help maintain low
expression of some mRNAs. This study showed that TF-, cell cycle-
and DNA damage-mRNAs were mainly restricted to low expression
by the CCR4–NOT complex in the liver (Figs 3 and 4). This role of the
CCR4–NOT complex is important in liver homeostasis because
excess cell cycle- and DNA damage-mRNAs are unfavorable for
cells and mature tissues. Indeed, suppression of the CCR4–NOT
complex altered cellular homeostasis, tissue development, and
tissue function (Aslam et al, 2009; Mittal et al, 2011; Inoue et al, 2015;
Yamaguchi et al, 2018; Suzuki et al, 2019). Importantly, TF-mRNAs
have significantly shorter half-lives compared with other mRNA
species and undergo rapid decay in several cell lines, including
hepatic cells (Yang et al, 2003), suggesting that regulation of TF-
mRNAs by the CCR4–NOT complex also contributes to liver ho-
meostasis. On the other hand, liver function–related mRNAs were
only moderately controlled by the CCR4–NOT complex. Those
mRNAs are generally active in translation to ensure liver function.
Figure 8. Cytoplasmic localization of CCR4–NOT
complex subunits.
(A) Immunoblot analysis of cytoplasmic and nuclear
fractions isolated from livers of control (Cnot1fl/fl) and
Cnot1-LKO mice using the indicated antibodies (n =
3). (A, B) Quantification of the immunoblot results in
(A). Proteins in the cytoplasmic and nuclear fractions
were normalized with GAPDH and LAMIN B,
respectively. Values in graphs represent means ± SEM.
Unpaired t test, *P < 0.05, ***P < 0.001.
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We hypothesize that they are protected from mRNA decay because
active translation status contributes to mRNA stabilization and
suppression of translation repression is coupled with mRNA deg-
radation (Hendrickson et al, 2009; Guo et al, 2010; Edri et al, 2014).
Taken together, by facilitating shortening of poly(A) tail lengths of
mRNAs, the CCR4–NOT complex maintains liver health.
Several lines of evidence show that the CCR4–NOT complex
directly regulates transcription. In Saccharomyces cerevisiae, the
Ccr4–Not complex interacts with Tbp and Taf proteins to suppress
transcription initiation (Collart & Struhl, 1994; Badarinarayana et al,
2000; Miller & Reese, 2012), whereas it stimulates transcription
elongation through interaction with RNA polymerase II (Kruk et al,
2011). In mouse embryonic stem cells and progressive cancer cell
lines, the CCR4–NOT complex is localized in the nucleus and binds
to the promoter region of self-renewal genes (Hu et al, 2009; Cejas
et al, 2017). The CCR4–NOT complex interacts with nuclear receptors,
such as RXR and ERα, and regulates transcription of their target
genes in a ligand-dependent manner (Nakamura et al, 2004;
Winkler et al, 2006; Garapaty et al, 2008). Furthermore, the CCR4–
NOT complex binds to the TF, EBF1, and modifies B-cell differ-
entiation (Yang et al, 2016). However, we hardly detected the
CCR4–NOT complex in liver nuclear fractions, suggesting indirect
involvement of the CCR4–NOT complex in transcription in the liver
(Fig 8). One possibility is that stabilization of TF-mRNAs and sub-
sequent increases of the proteins influences transcriptional pro-
grams. Especially, Trp53- and IRF-induced transcription appears to
be involved because many genes that increased in the livers from
Cnot1-LKOmice at pre-mRNA levels had binding elements for those
TFs in their promoter regions (Fig S9). Indeed, Trp53-dependent
transcriptional activation has considerable effects on abnormali-
ties observed upon suppression of the CCR4–NOT complex in
B-cells and heart (Inoue et al, 2015; Yamaguchi et al, 2018). RNA
polymerase II loading on a genomic region of the Gck gene de-
creased in the livers from Cnot1-LKO mice (Fig 7D). When tran-
scription of DNA damage response- or immune system process
genes is extensively induced, transcription of liver function–related
genes may be limited. Decreases in mRNA decay rates in Cnot1-LKO
mice might be balanced by adjustments in mRNA synthesis rate. It
will be interesting to determine whether transcript buffering occurs
in the livers of Cnot1-LKO mice because this phenomenon is well
established in yeast, but not in other species yet (Timmers & Tora,
2018).
Previous reports showed that changes in pre-mRNA levels are
significantly correlatedwith those in transcription rates (Gaidatzis et al,
2015; Wang et al, 2018). Here, we showed that suppression of the
CCR4–NOT complex also influenced the abundance of pre-mRNAs.
Consequently, whereas TF-, cell cycle-, and DNA damage-mRNAs in-
creased, liver function–related mRNAs decreased. ChIP experiments
imply that different expression levels of pre-mRNAs are due at least in
part to changes in transcription rate. We analyzed only some of the
genes; thus, we cannot exclude the possibility that other mechanisms
such as splicing, nuclear RNA decay, or nuclear RNA export might be
responsible for changes in pre-mRNA levels. It is also possible that
decreased levels of mRNAs encoding liver function–related molecules
are only relative to other mRNA species that increased significantly in
livers of Cnot1-LKO mice. Further analyses are necessary to clarify the
molecular mechanism by which CNOT1 suppression leads to global
changes in mRNA expression in the liver.
RIP experiments showed that mRNAs preferentially bound by the
CCR4–NOT complex overlap with those targeted by BRF1 and AGO2,
suggesting that BRF1 and AGO2 contribute to CCR4–NOT complex–
dependent mRNA decay in the liver. Liver-specific suppression of Ago2
did not induce obvious abnormalities during development or in adult-
hood (Zhang et al, 2018). Liver-specific Brf1-deficient mice displayed
abnormal bile acid and lipid metabolism, although an appearance of
inflammatoryphenotypeswasnotdescribed (Tarlinget al, 2017). Although
AGO2 could be compensated because of potentially overlapping roles of
other family proteins such as AGO1 (Dueck et al, 2012), our results suggest
that a set of mRNAs is redundantly controlled by BRF1 or AGO2. It should
be noted that not all mRNAs bound by the CCR4–NOT complex are
explained by BRF1- or AGO2-mediated mechanisms (Fig 6G). Other RNA-
binding proteins (RBPs) are involved in the regulation of those mRNAs.
Indeed, the CCR4–NOT complex uses various RBPs to recognize target
mRNAs (Chang et al, 2004; Chicoine et al, 2007; Hosoda et al, 2011; Leppek
et al, 2013; Bhandari et al, 2014;Ogamiet al, 2014; Sgromoet al, 2017; Yamaji
et al, 2017). Our results suggest that RBPs that recognize sequences
enriched with U or A may be good candidates (Fig S7).
Fulminant hepatitis causes acute, severe liver injury as a result
of massive hepatocyte apoptosis and necrosis induced by death
receptor signaling, involving FAS, TNF receptor, and TNFSNF10b,
leading to lethality (Malhi et al, 2010). Our liver-specific Cnot1
disruption model minimized extrahepatic causes, and the phe-
notype was reproducible and irreversible under our experimental
conditions. Thus, Cnot1-LKO mice could be added to hepatitis
models to help develop therapeutics for fulminant hepatitis.
Because the Cnot1 gene has single nucleotide polymorphisms
that are associated with hepatitis C virus infection and hepatic
toxicity (Li et al, 2009; Dzikiewicz-Krawczyk, 2015), studies using
clinical samples may reveal the relationship between dysfunction
of the CCR4–NOT complex and the onset of hepatitis.
Materials and Methods
Mice
Cnot1 conditional KO (Cnot1fl/fl) mice (Accession No CDB0916K: http://
www2.clst.riken.jp/arg/mutant%20mice%20list.html) were generated
with TT2 ES cell lines (Yagi et al, 1993) as described previously (http://
www2.clst.riken.jp/arg/methods.html). To generate conditional alleles
(floxed alleles) from targeted alleles, mice with targeted alleles were
crossed with mice expressing FLP (#009086; Jackson Laboratory).
Wild-type, floxed, and KO alleles were detected with PCR primers: 59-
CCACTGACTTGACACTATTAGTGTGAAAGG-39 for the forward primer of
wild-type, floxed, and KO alleles, 59-CCAGAGCTGTCTAGGCAGACAAGG-
39 for the reverse primer of wild-type and floxed alleles, and 59-
CCAGGTGCTGACAATACTGAGGATAGTCC-39 for the reverse primer of a
KO allele. PCR product sizes for wild-type, floxed, and KO alleles were
279, 492, and 732 bp, respectively. The absence of FLP knock-in
alleles in mice with floxed alleles was also confirmed by PCR. We
backcrossed Cnot1fl/fl mice with C57BL/6J mice for at least eight
generations. Mice were maintained on a 12-h light/dark cycle in a
temperature-controlled (22°C) barrier facility with free access to
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water and a normal diet (NCD, CA-1, CLEA Japan, Inc.). Alb-CreERT2
mice that express tamoxifen-dependent CreERT2 recombinase
under the control of the albumin gene promoter were kindly
provided by Dr Pierre Chambon (Schuler et al, 2004). We produced
Cnot1fl/fl;Alb-CreERT2 mice by crossing Cnot1fl/+;Alb-CreERT2 pairs,
which were from mating Cnot1fl/fl mice with Alb-CreERT2 mice. To
induce Cre-mediated somatic recombination for deletion of the
Cnot1 gene in adult mice, 6-wk-old Cnot1fl/fl;Alb-CreERT2mice were
fed with a 0.025% tamoxifen-containing normal diet (Research
Diets Inc.) for 2 wk, unless otherwise indicated. Tamoxifen-fed
Cnot1fl/fl;Alb-CreERT2 mice were used as Cnot1-LKO mice. Alb-
CreERT2 and Cnot1fl/fl mice were similarly treated as controls. We
collected blood samples and measured glucose concentrations
with a glucometer (Glutest Pro; Sanwa Kagaku Kenkyusho). Mouse
experiments were approved by the Committee of Animal Exper-
iments in the Okinawa Institute of Science and Technology
Graduate University and by the Institutional Animal Care and Use
Committee at RIKEN, Kobe Branch.
Antibodies
Mouse monoclonal antibodies against CNOT1, CNOT3, CNOT6L,
CNOT8, and CNOT9 were generated by Bio Matrix Research (Suzuki
et al, 2015; Takahashi et al, 2015). Antibodies against phospho-JNK
(Thr183/Tyr185) (#4671), Cleaved Caspase-3 (Asp175) (#9661), CNOT2
(#34214), RPB1 (#2629), and GAPDH (#2118) were purchased from Cell
Signaling Technology. Antibodies against JNK (sc-474), BAX (sc-493),
p53 (sc-126), and LAMIN B (sc-6217) were from Santa Cruz Bio-
technology. Antibodies against CNOT7 (H00029883-M01A) from
Abnova, and RNA Polymerase II (ab817), TBP (ab51841), and IRF9
(ab231015) from Abcam.
Histological analysis of tissue
After dissection, the livers were fixed with 10% formaldehyde
overnight and embedded in paraffin. Sections were stained with
Hematoxylin 3G (8656) and Eosin (8659) from Sakura Finetek Japan.
Immunohistochemistry for cleaved caspase-3 protein was per-
formed with an antibody against Cleaved Caspase-3 (#9661), as
previously described (Suzuki et al, 2019). We captured images and
counted the number of apoptotic cells using BZ X-700 (Keyence). We
prepared sections from two or three mice of each genotype (Alb-
CreERT2, Cnot1fl/fl, or Cnot1-LKO). The representative image of each
genotype is shown. H&E–stained sections were analyzed for in-
flammation, steatosis, and necrosis according to the following
scoring system: (i) for inflammation: 0, no inflammation; 1, mild
lymphocytic infiltration in the portal triad; 2, severe lymphocytic
infiltration in portal triad; 3, extended infiltration of lymphocytes
throughout liver; (ii) for steatosis: 0, no steatosis; 1, microsteatosis;
2, microsteatosis and mild macrosteatosis; 3, severe macro-
steatosis; (iii) for necrosis: 0, no necrosis; 1, mild necrosis; 2,
moderate necrosis; 3, severe necrosis. All scoring was performed by
a pathologist blinded to the genotypes.
Biochemical examination of blood
Plasma for each analysis was obtained by cardiac puncture from
deeply anesthetized mice after overnight fasting and was analyzed
by the Oriental Yeast Co. Ltd.
Total RNA-sequencing
Total RNA was isolated from the liver of control (Alb-CreERT2 and
Cnot1fl/fl) and Cnot1-LKO mice. For comprehensive mRNA half-life
profiling, we intraperitoneally injected Act. D (Wako) (2 mg/g body
weight) into control (Cnot1fl/fl) and Cnot1-LKOmice after a tamoxifen-
containing diet feeding for 2 wk. We collected livers at 0 h (no in-
jection, n = 4), 4 h (n = 3 in control, n = 4 in Cnot1-LKO), and 8 h (n = 3 in
control, n = 5 inCnot1-LKO) after injection and extracted total RNAs. At
8 h after Act. D treatment, we did not see any obvious abnormalities
in themice. Total RNA (1μg) was used for RNA-seq library preparation
with a TruSeq Stranded mRNA LT Sample Prep Kit (Illumina), which
allows polyA-oligo(dT)–based purification of mRNA, according to the
manufacturer’s protocol. 109-bp, paired-end read RNA-seq was
performedwith a HiSeq PE Rapid Cluster Kit v2-HS and a HiSeq Rapid
SBS Kit v2-HS (200 Cycle) on a HiSeq 2500 (Illumina), according to the
manufacturer’s protocol. For data analysis, using StrandNGS software
(Strand Genomics, Inc.), reads were mapped to the Ensembl genome
sequence (mm10) and FPKMs were calculated. We excluded genes
with <0.00015 FPKM. For calculation of mRNA half-lives, gene
FPKMs were normalized with the FPKM of Rplp0 mRNA because
mRNA quantity per total RNA would decrease upon transcription
suppression in Act. D–treated samples. We used the mean of
normalized gene FPKMs obtained from independent experiments
at each time point, and we calculated mRNA half-lives. The in-
tercept and slope of the linear regression line were applied
according to the formula: LN(0.5/e^intercept)/slope (Chen et al,
2008). mRNAs with half-lives less than 0 h or more than 50 h were
excluded as unreliable. For calculating intronic FPKMs, reads
mapped to the intronic region were extracted with StrandNGS
software and read numbers were normalized using the total count
of reads mapped to the intronic region and the sum of intron
lengths. Genes with <0.01 FPKM and <30-bp intron lengths were
eliminated. Sequence data are available through ArrayExpress
under the accession number (E-MTAB-5901).
RIP-sequence (RIP-seq)
Livers from 8-wk-old wild-type mice were homogenized and sol-
ubilized in TNE buffer (50 mM Tris–HCl [pH 7.5], 150 mM NaCl, 1 mM
EDTA, 1% NP40, and 1 mM PMSF) for 30 min at 4°C. Lysates (150 mg)
were incubated with 180 μg of antibodies against CNOT3 and AGO2
(018-22021; Wako) and 100 μl of antibody against BRF1 (#2119; Cell
Signaling Technology) for 1 h at 4°C, and then incubated with 1.2 ml
of Dynabeads (Invitrogen) for 2 h at 4°C. Total RNAs in immuno-
precipitates were isolated using Isogen II. Immunoprecipitates were
also analyzed by immunoblotting. Following the manufacturer’s
protocol, we used 100 ng of total RNA for RNA-seq library prepa-
ration with a TruSeq Stranded mRNA Library Prep Kit for NeoPrep
(NP-202-1001; Illumina), which allows polyA-oligo(dT)–based puri-
fication of mRNA. Minor modification and optimization were
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implemented as follows. Custom dual index adaptors were ligated
at the 59- and 39 ends of the library, and PCR was performed for 11
cycles. 150 bp pair-end read RNA-seq was performed with HiSeq
3000/4000 PE Cluster Kit (PE-410-1001; Illumina) and HiSeq 3000/
4000 SBS Kit (300 Cycles) (FC-410-1003; Illumina) on HiSeq 4000
(Illumina), according to the manufacturer’s protocol. For data
analysis, using StrandNGS (Strand Genomics, Inc.), reads were
mapped to the Ensembl genome sequence (mm10) and FPKMs were
calculated. Genes with <0.1 FPKM in both input and RIP samples
were excluded. The RIP enrichment value was calculated by division
of gene FPKMs in RIP by that in input total RNA. We used the mean
(or median) of the values in three independent expressions, as
indicated in figure legends. Sequence data are available through
ArrayExpress under accession number (E-MTAB-6941).
Primary hepatocyte isolation
Adult mice (8-wk-old) were subjected to collagenase perfusion. The
liver was perfused with collagenase solution, 18 mM Hepes–NaOH
[pH 7.4], 0.075% NaHCO3, 0.5 μg/ml insulin, and 0.1 mg/ml colla-
genase (C2674; Sigma-Aldrich) in 1× Hank’s solution, through the
portal vein. Perfused hepatocytes were washed with PBS three
times and lysed with TNE buffer.
Gel filtration chromatography
Liver was lysed with TNE buffer. Lysates (0.5 ml, 3.5 mg/ml) were
applied to a Superose 6 10/300 GL column using an AKTA Pure (GE
Healthcare). The flow rate was 0.5 ml/min and 0.5 ml fractions were
collected.
Quantitative real-time PCR
Total RNA was isolated from livers using Isogen II (Nippon Gene).
cDNA was generated with total RNA (1 μg), oligo (dT) primers
(Thermo Fisher Scientific), and SuperScript Reverse Transcriptase III
(Thermo Fisher Scientific). We used random primers (Thermo Fisher
Scientific) for cDNA synthesis to monitor Rplp0 and 18S rRNA levels
during Act. D treatment (Fig S5). cDNA was mixed with primers and
SYBR Green Supermix (Takara) and analyzed with a Viia 7 sequence
detection system (Applied Biosystems). Relative mRNA expression
was determined after normalization with Rplp0 or pre-Rplp0 levels
using the ΔΔCt method for mRNAs or pre-mRNAs, respectively.
Primers are listed in Table S10.
ChIP assay
Livers dissected from control (Cnot1fl/fl) and Cnot1-LKO mice were
diced into small pieces (~5 mm cubes) and fixed with 1% formal-
dehyde in phosphate-buffered saline at 37°C for 15min, followed by
two PBS washes. We used anti-RNA Polymerase II antibody and a
SimpleChIP Enzymatic Chromatin IP Kit (#9003; Cell Signaling
Technology) to prepare nuclear fractions, and for chromatin
fragmentation and subsequent immunoprecipitation, with modi-
fications. Briefly, after treatment with 150 units of micrococcal
nuclease for 20 min at 37°C, cross-linked chromatin was incubated
with 2 μg of anti-RNA Polymerase II antibody (ab817) or ChIP grade
mouse control IgG (ab18143) at 4°C for 24 h. Immunoprecipitates
were washed, and DNA was eluted and de–cross-linked as de-
scribed previously (Takahashi et al, 2012). The final products (DNA
fragments) were analyzed by qRT-PCR. We used the same primers
as for detection of precursor mRNAs. Primers are listed in Table S10.
Immunoblotting
Livers were homogenized and solubilized in TNE buffer (50 mM
Tris–HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% NP40, and 1 mM PMSF)
for 30 min at 4°C. Lysates dissolved in SDS sample buffer were
subjected to SDS–polyacrylamide gel electrophoresis followed by
electro-transfer onto Immobilon-P membranes (Millipore). Protein
bands were blotted with primary antibodies and ECL anti-rabbit or
mouse IgG HRP-linked whole antibody (GE Healthcare) as the sec-
ondary antibody. For detection, we used Immobilon Western HRP
substrate (Millipore). To quantify the results, we used ImageQuant
software in an Image Analyzer LAS 4000 mini (GE Healthcare).
Subcellular fractionation
Livers were homogenized with hypotonic buffer (10 mM Hepes, 10
mM KCl, and 1.5 mMMgCl2). After centrifugation at 11,000 g for 10 min
at 4°C, supernatants (cytoplasm) and pellets (nuclei) were dis-
solved in SDS sample buffer. Nuclear fractions and corresponding
amounts of the cytoplasmic fraction were analyzed by immuno-
blotting. For quantification, ImageJ software was used to measure
protein band intensity. Proteins in the nucleus and the cytoplasm
were normalized with LAMIN B and GAPDH, respectively.
Poly(A) tail assay
Poly(A) tail lengths of mRNAs were analyzed using Poly(A) Tail-
Length Assay Kits (Affymetrix), according to the manufacturer’s
protocol. Briefly, 1 μg of total RNA was incubated with poly(A)
polymerase in the presence of guanosine (G) and inosine (I) to add
a GI tail at the 39-ends of poly(A)-containing RNAs. cDNA was
generated with PAT (PCR poly(A) test) universal primer and reverse
transcriptase using GI-tailed RNA as a template. PCR amplification
was performed with gene-specific and PAT universal primers and
HotStart-IT Taq DNA polymerase. We treated 1 μg of total RNA with
0.2 U of RNase H (Invitrogen), which degrades the RNA strand of
RNA-DNA hybrids, at 37°C for 30 min in the presence of 5 μM of the
oligo (dT) primer (TTTTTVN; Invitrogen), to remove poly(A) se-
quences from mRNA and then performed subsequent adaptor
ligation, reverse transcription, and PCR reaction. The 0 position of
poly(A) tails (A0) was determined from the size of PCR products
after RNase H treatment in the presence of oligo (dT). Primers
used in these experiments are listed in Table S10. We performed
poly(A) tail assays using total RNA prepared from two indepen-
dent mouse livers in each genotype. For measurements of bulk
poly(A) tail lengths, 10 μg of total RNA was labeled with [59-32P] pCp
(cytidine 39,59-bis[phosphate]) (0.11 pmol/μl in total reaction
volume 30 μl) (NEG019A; PerkinElmer) using T4 RNA ligase 1
(M0204S; New England Biolabs) at 16°C overnight. Labeled RNAs
were incubated at 85°C for 5 min and placed on ice. Then, labeled
RNAs were digested with Ribonuclease A (Sigma-Aldrich) and
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Ribonuclease T1 (Thermo Fisher Scientific) at 37°C for 120 min in
digestion buffer (100 mM Tris–HCl [pH 7.5], 3M NaCl). Reactions
were stopped by adding 5× stop solution (10 mg/ml Proteinase K,
0.125 mM EDTA, and 2.5% SDS) and subsequently incubating at
37°C for 30 min. After adding 400 μl of RNA precipitation buffer (0.5
M NH4OAc and 10 mM EDTA), digested RNA samples were purified
by phenol–chloroform extraction and isopropanol precipitation.
Final products were fractionated on 8M urea–10% polyacrylamide
denaturing gels. Markers (Prestain Marker for small RNA Plus,
DM253; BioDynamics Laboratory) were also loaded. Gels were
analyzed with a Typhoon FLA 9500 Fluorescence Imager (GE
Healthcare). Band intensity was quantified using Image J.
Bioinformatic analysis
GO enrichment analysis was performed with DAVID Bioinformatics
Resources 6.8 (https://david.ncifcrf.gov). GO IDs used in the ana-
lyses were transcription (GO:0006351), apoptotic process (GO:
0006915), immune system process (GO:0002376), cell cycle (GO:
0007049), cellular response to DNA damage stimulus (GO:0006974)
and oxidation–reduction process (GO:0055114), and lipid metabolic
process (GO:0006629). Violin plots were generated using the R
system. Consensus motifs in the promoter region and 39UTRs were
analyzed using HOMER and Amadeus software, respectively. When
genes had multiple transcript variants, we first chose transcripts
with the smallest Transcript Support Level. When we still had
multiple candidates, we chose the one with the longest transcript
length.
Statistical analyses
Comparisons were made using unpaired t test, Wilcoxon rank sum,
and Wilcoxon signed-rank tests. Values represent means ± SEM and
are represented as error bars. We also used Spearman’s correlation
coefficient or Pearson’s correlation coefficient, as noted in figure
legends. Statistical significance is as indicated.
Accession number
RNA-seq and RIP-seq data are available through ArrayExpress
under accession numbers (E-MTAB-5901) and (E-MTAB-6941),
respectively.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201900494.
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